Featured Biotech ETFs Are Already Benefitting from Pfizer Vaccine’s Full Approval By Ian YoungAugust 23, 2021
Nasdaq Investment Intelligence Channel Bet on Biotech Small Caps to Bounce Back By Tom LydonAugust 19, 2021
Multi-Asset Channel The Blank-Check Boom: ‘SPAK’ Hits $100 Million in AUM By Tom LydonFebruary 16, 2021
Innovative ETFs Channel Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021 By Max ChenDecember 31, 2020
Nasdaq Investment Intelligence Channel Young But Hungry: A New Defiance ETF is Defying Expectations By Tom LydonNovember 13, 2020
Disruptive Technology Channel Could Apple’s New iPhone Help Boost 5G ETFs? By Ian YoungOctober 12, 2020